戻る Agenda
Session 3: Latest information from ClinicalTrials.gov
Session Chair(s)
Robert Paarlberg, MS
Principal, Paarlberg & Associates LLC, United States
This session will include an update from ClinicalTrials.gov regarding National Library of Medicine’s Modernization initiative as well as other recent developments. It will also include an industry perspective regarding: Modernization initiative; National Institutes of Health’s July 28th letter to sponsors on submitting results for pACTs; enforcement actions following FDA’s final guidance on Civil Monetary Penalties; and, ClinicalTrials.gov’s new practice of publishing results without review.
Speaker(s)
Rebecca Williams, PharmD, MPH
Senior Clinical Trials Subject Matter Expert, Essex Management, Part of Emmes Group, United States
Updates on Modernisation Initiatives & COVID-19 Activities in ClinicalTrials.gov
Gregory Shear, MS
Disclosure Services Lead, ClaritiDox, United States
Industry Experience